What is RNXT stock price today?

RNXT (Renovorx Inc) stock is trading at $0.87 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is RNXT stock going up or down today?

RNXT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy RNXT stock now?

The decision to buy RNXT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is RNXT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for RNXT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is RNXT stock overvalued or undervalued?

Use our DCF valuation calculator to determine if RNXT is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is RNXT's P/E ratio?

P/E ratio data for RNXT will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is RNXT's market cap?

RNXT (Renovorx Inc) has a market capitalization of $0.04 billion, making it a small-cap stock.

What is RNXT's price to book ratio?

RNXT trades at a price-to-book (P/B) ratio of 7.22, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does RNXT pay dividends?

RNXT does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is RNXT's dividend yield?

RNXT does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is RNXT stock a good long-term investment?

RNXT's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is RNXT's revenue growth rate?

RNXT has shown revenue growth of 4.5% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for RNXT are available on our dashboard with complete income statement analysis.

What are the risks of investing in RNXT?

Key risks for RNXT include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does RNXT compare to its competitors?

Compare RNXT to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize RNXT's performance and positioning.

What is RNXT's stock price target for 2026?

Our AI model provides price targets for RNXT based on fundamental analysis: Bull case $1.13 (+30%), Base case $1.00 (+15%), Bear case $0.79 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about RNXT?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for RNXT. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is RNXT's next earnings report?

RNXT reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

RNXT - Renovorx Inc

NYSE * Health Care * Biotechnology

$0.87

+$0.02 (+2.68%)

About Renovorx Inc

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.

RNXT Key Statistics

Market Cap

$38.29M

P/B Ratio

7.22

EPS

$-0.32

Revenue Growth

+4.5%

Employees

How RNXT Compares to Peers

RNXT has the fastest revenue growth among competitors

RNXT is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
RNXT(This stock)	$38.29M	N/A	5%	0.0%	-
AMGNAmgen Inc	$177.98B	22.9	0%	0.2%	vs AMGN
GILDGilead Sciences	$165.77B	18.2	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$110.45B	25.8	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$74.73B	17.4	0%	0.3%	vs REGN
BIIBBiogen Inc	$29.22B	21.3	0%	0.1%	vs BIIB

Renovorx Inc Company Information

Headquarters: California; U.S.A
Website: renovorx.com
Sector: Health Care
Industry: Biotechnology

Data Updated: May 13, 2026 at 1:32 PM EDT

Ready to invest in RNXT?

Commission-free trading available. Affiliate links.

RNXT Lician Score

5% confidence

5.0/10

Neutral

RNXT has a Lician Score of 5/10 (Average). The stock shows average characteristics across all dimensions.

value

5.0

growth

4.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates RNXTacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

RNXT Financial Snowflake

5-axis analysis across key investment dimensions

4.8/10

Neutral

5.0

Value

Valuation vs. sector peers

4.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for RNXT

Dashboard

Enter a ticker to analyze